Join the Constipation group to help and get support from people like you.
Constipation News (Page 2)
Related terms: Difficulty passing stool, Irregularity of bowels
FDA Approves Symproic (naldemedine) for the Treatment of Opioid-Induced Constipation
OSAKA, Japan and FLORHAM PARK, N.J. and STAMFORD, Conn., March 23, 2017 /PRNewswire/ – Shionogi Inc. and Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved...
U.S. FDA Approves 72 mcg Dose of Linzess (linaclotide) for Adults with Chronic Idiopathic Constipation
CAMBRIDGE, Mass. and DUBLIN, Jan. 26, 2017 /PRNewswire/ – Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the U.S. Food and Drug Administration (FDA)...
FDA Approves Trulance (plecanatide) for Chronic Idiopathic Constipation
January 19, 2017 – The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients. “No one medication works f...
Valeant and Progenics Announce FDA Approves Relistor Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain
LAVAL, Quebec and TARRYTOWN, N.Y., July 19, 2016 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that...
FDA Medwatch Alert: Oral Liquid Docusate Sodium by PharmaTech : Recall - Contaminated with B. cepacia
ISSUE: The FDA is alerting health care professionals that PharmaTech LLC, Davie, Florida, is voluntarily recalling all non-expired lots of Diocto Liquid, a docusate sodium solution distributed by...
FDA Approves Movantik (naloxegol) for Opioid-Induced Constipation
September 16, 2014 – The U.S. Food and Drug Administration today approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain. Opioids are...
FDA Medwatch Alert: Sodium Phosphate Over-the-Counter Products: Drug Safety Communication - Possible Harm From Exceeding Recommended Dose
Marketed under the brand-name Fleet, and as store brands and generic products. [Posted 01/08/2014] ISSUE: FDA is warning that using more than one dose in 24 hours of over-the-counter (OTC) sodium ...
FDA Approves Amitiza for Opioid-Induced Constipation
BETHESDA, Md. & DEERFIELD, Ill.--(BUSINESS WIRE)--Apr. 23, 2013-- Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that the United States (U.S.) Food and Drug...
FDA Approves Linzess to Treat Certain Cases of Irritable Bowel Syndrome and Constipation
August 30,2012 – The U.S. Food and Drug Administration today approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation (IBS-C)...
Further information
Related condition support groups
Constipation - Chronic, Constipation - Acute, Chronic Idiopathic Constipation, Gastrointestinal Disorders
Related drug support groups
Peri-DS, MiraLax, magnesium citrate, Dulcolax, Metamucil, lactulose, Fleet Enema, Colace, Milk of Magnesia, magnesium oxide, bisacodyl, polyethylene glycol 3350